What is the Mechanism of Action of Drug Saroglitazar, Which is most commonly used in Metabolic Associated Steatohepatitis?
- A. Predominant PPAR-γ activation → increased insulin sensitivity + decreased triglycerides
- B. Predominant PPAR-α activation + moderate PPAR-γ activation → improved lipid metabolism + insulin sensitivity
- C. PPAR-α antagonism + PPAR-γ activation → reduced hepatic gluconeogenesis
- D. PPAR-α activation + GLP-1 receptor agonism → increased insulin secretion + triglyceride reduction
0
voters
MBH/PS